Shelly Kafka

Once‐weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial

Edward Keystone, Michael Schiff, Joel M. Kremer et al. · Arthritis & Rheumatism · 2004 · 286 citations

Medicine, Pharmacology, Pharmacotherapy +8

Melanoma, Growth Factors, Acanthosis Nigricans, the Sign of Leser-Trélat, and Multiple Acrochordons

Darrel L. Ellis, Shelly Kafka, J.C. Chow et al. · New England Journal of Medicine · 1987 · 235 citations

Medicine, Dermatology, Oncology +17

Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials

Philip Helliwell, Dafna D. Gladman, Soumya D. Chakravarty et al. · RMD Open · 2020 · 64 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologics

Christopher T. Ritchlin, Mona Ståhle, Yves Poulin et al. · BMC Rheumatology · 2019 · 37 citations · Full text

Medicine, Clinical Sciences, Immunology +15

Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies

Dennis McGonagle, Iain B. McInnes, Atul Deodhar et al. · Lara D. Veeken · 2021 · 34 citations · Full text

Medicine, Immunology, Pharmacotherapy +13